‘A positive step’: oral antivirals confirmed for Doctor’s Bag After extensive RACGP lobbying, GPs now have enhanced access to COVID-19 oral antiviral treatments for urgent use among at-risk patients.
Study identifies link between COVID-19 and Parkinson’s Researchers say the virus aggravates brain cells similar to neurodegenerative conditions, flagging potential future risk, but also treatments.
Survey hints at increasing long COVID burden Half of the nearly 2200 people surveyed by Lung Foundation Australia reported ongoing symptoms more than four weeks after their initial infection.
New variants expected to supplant BA.5 in Australia Both XBB and BQ.1 possess a growth advantage over previous COVID strains, but there is no evidence to suggest either variant is more severe.
Vaccine and infection myocarditis risks contrasted A new Immunisation Coalition chart illustrates the much higher myocarditis risks following COVID-19 infection compared to vaccination.
TGA approves Moderna as adolescent booster An ongoing study demonstrates that the booster produces a similar immune response in this cohort to adults aged 18–25, the regulator says.
How stress can increase the chances of long COVID People with psychological distress in the lead up to their COVID infection have more chance of ongoing symptoms, writes Dr Susannah Tye.
Enhanced antivirals access a victory for patients RACGP Vice President Dr Bruce Willett goes behind the scenes of a successful campaign to help GPs supply oral antivirals to at-risk patients.
Stronger myocarditis warnings after death linked to vaccine The stronger product information warning follows the death of a woman in her 20s, who died after receiving a Moderna booster.
How scrapped iso requirements impact telehealth The end of COVID isolation also means fewer exemptions to the 12-month telehealth rule.